| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $873K | -0.0% |
| R&D Expense | $11.8M | -6.5% |
| SG&A Expense | $18.4M | +75.8% |
| Operating Income | -$40.7M | -83.3% |
| Interest Expense | $775K | +20.8% |
| Pre-tax Income | -$44.1M | -92.6% |
| Net Income | -$43.2M | -88.8% |
| EPS (Basic) | -$1.68 | -32.3% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.2M | +131.7% |
| Accounts Receivable | $322K | -24.2% |
| Current Assets | $92.9M | +149.7% |
| Total Assets | $99.2M | +144.8% |
| Current Liabilities | $10.7M | +181.9% |
| Long-term Debt | $200K | -96.0% |
| Total Liabilities | $21.0M | +108.6% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.1M | -17.8% |
| Capital Expenditures | $1.4M | +55.0% |
| Investing Cash Flow | -$1.4M | -62.8% |
| Financing Cash Flow | $79.5M | +161.9% |
| Free Cash Flow | -$24.5M | -19.4% |
| Stockholders' Equity |
| $72.7M |
| +138.7% |